Related Concept Videos
Obedience
Drug Therapy
Antianxiety Medications
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Psychosis: Goals of Pharmacotherapy
Legal Guidelines for Documentation
Accountability and Responsibility of a Nurse II
For example, a nurse demonstrating respect and compassion might listen attentively to a patient's concerns, provide comfort...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Aldosterone and aldosterone/cortisol ratio is higher in serum of long-term compared to first episode schizophrenia patients: A pilot study.
Treatment of panic disorder: Algorithms for pharmacotherapy.
Optimizing treatment with risperidone long-acting injections.
Related Experiment Video
Updated: Jun 10, 2026

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
Published on: August 22, 2014
[Compliance in psychiatry].
1Psychiatrickă klinika LF MU a FN Brno, Jihlavská 20, 625 00 Brno. eceska@med.muni.cz
Improving patient compliance in schizophrenia is crucial for preventing relapses. Atypical antipsychotics offer better tolerability and formulation options, aiding long-term treatment adherence.
Area of Science:
- Psychiatry
- Clinical Medicine
- Pharmacology
Context:
- Patient compliance is a significant challenge across all medical fields, particularly in psychiatric care.
- Low adherence rates in severe psychotic disorders like schizophrenia increase relapse risks and negatively impact illness trajectory.
- Understanding patient-specific factors and treatment options is vital for effective management.
Purpose:
- To highlight the importance of patient compliance in managing severe psychotic disorders, especially schizophrenia.
- To discuss strategies for improving treatment adherence in psychiatric patients.
- To evaluate the role of atypical antipsychotics in enhancing compliance and long-term outcomes.
Summary:
- Compliance issues are more pronounced in psychiatric patients compared to those with somatic illnesses.
Impact:
- Enhanced patient compliance can lead to reduced relapse rates and improved long-term outcomes in schizophrenia.
- The selection of appropriate psychopharmacotherapeutic agents, like atypical antipsychotics, can significantly influence treatment adherence.
- Optimizing treatment strategies based on patient-specific factors and drug characteristics is key to overcoming compliance barriers in psychiatric care.
